Trinity Biotech reported $124.72M in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Bayer BAYN:GR € 116549M 2122M
Bio Rad Laboratories BIO:US $ 19953.38M 4835.82M
Cytori Therapeutics CYTX:US $ 24.75M 3.92M
Mesa Laboratories MLAB:US $ 609.1M 3.39M
Orasure Technologies OSUR:US $ 455.76M 9.29M
Oxford Immunotec Global OXFD:US $ 210.5M 3.89M
Siemens SIE:GR € 139608M 2777M
Sientra SIEN:US $ 186.66M 3.87M
Surmodics SRDX:US $ 194.59M 17.39M
Thermo Fisher Scientific TMO:US $ 73600M 5902M
Tosoh 4042:JP Y 1021375M 33198M
Trinity Biotech TRIB:US $ 124.72M 11.26M
Veracyte VCYT:US $ 1186.36M 158.92M